Nektar Therapeutics
NKTR
#4923
Rank
A$2.59 B
Marketcap
A$92.68
Share price
-6.35%
Change (1 day)
399.91%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): A-$12.36

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$11.21. In 2024 the company made an earnings per share (EPS) of A-$12.46 an increase over its 2023 EPS that were of A-$30.80.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$12.36-0.83%
2024A-$12.46-59.54%
2023A-$30.80-25.89%
2022A-$41.56-31.12%
2021A-$60.3314.86%
2020A-$52.53-1.19%
2019A-$53.16-163.96%
2018A$83.12-725.4%
2017A-$13.29-42.73%
2016A-$23.2183.33%
2015A-$12.6639.53%
2014A-$9.07-69.29%
2013A-$29.53-6.67%
2012A-$31.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.66-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.91-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.15-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$0.93-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.28-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.52-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$0.09845-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$2.91-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland